We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New Test Allows Simultaneous Processing of Four STDs

By LabMedica International staff writers
Posted on 06 Feb 2018
A new test allows simultaneous processing of any combination of four separate sexually transmitted infections: Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Trichomonas vaginalis (TV) and Mycoplasma genitalium (MG), from one patient sample.
 
Trichomonas vaginalis is the most common non-viral sexually transmitted infection (STI) in the world and roughly 70% of people infected with TV do not have any symptoms. More...
Mycoplasma genitalium is a fastidious bacterium and has been associated with male and female urethritis, balanoposthitis, prostatitis, cervicitis, pelvic inflammatory disease, and male and female infertility.
 
The new test cobas TV/MG (Roche, Pleasanton, CA, USA) is for use on the fully automated cobas 6800/8800 Systems that offer the fastest time to results, the highest throughput and the longest walk-away time available among automated molecular platforms, providing laboratories with improved operating efficiency and the flexibility to adapt to changing testing demands.
 
The cobas TV/MG offers laboratories the broadest set of specimen claims available in one test, including the ability to test for both TV and MG from one patient sample. This new flexibility can aid health care professionals in faster diagnosis and in reducing the testing volume for labs, while enabling fewer sample collections from patients. The cobas TV/MG has been validated for use with the same, full set of female urogenital specimens available for use with cobas CT/NG. In addition, the test has been validated for use with male urine and is the first CE-IVD molecular test to receive a claim for combo TV/MG testing using a meatal swab specimen.
 
Uwe Oberlaender, PhD, Head of Roche Molecular Diagnostics, said, “We are pleased to continue our commitment to expanding our portfolio for the detection of sexually transmitted infections. By coupling cobas TV/MG with recently launched cobas CT/NG for the detection of Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (NG), laboratories now have the most flexible, high throughput testing solution on the market today. Laboratories can now simultaneously process, from a single patient sample, any combination of CT, NG, TV and MG, which provides clinicians the valuable information they need to properly diagnosis STIs and improve patient care.”
 

New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated Microscope
dIFine
New
Staining Management Software
DakoLink
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.